Editorial
Doctors and the drug industry: How can we handle potential conflicts of interest?

https://doi.org/10.1016/j.amjmed.2004.12.003Get rights and content

References (21)

  • T.E. Finucane et al.

    Association of funding and findings of pharmaceutical research at a meeting of a medical professional society

    Am J Med

    (2004)
  • K. Morin et al.

    Managing conflicts of interest in the conduct of clinical trials

    JAMA

    (2002)
  • D. Korn

    Conflicts of interest in biomedical research

    JAMA

    (2000)
  • T.R. Cech et al.

    Conflicts of interest-moving beyond disclosure

    Science

    (2001)
  • B. Lo et al.

    Conflict of interest policies for investigators in clinical trials

    N Eng J Med

    (2000)
  • J. La Puma

    Physicians’ conflict of interest in post-marketing research: What the public should know, and why industry should tell them. Chapter in Research Ethics and Human Subjects: Facing the 21st Century

    (1995)
  • D.D. Federman et al.

    Responsible Research-A Systems Approach to Protecting Research Participants

    (2003)
  • N.G. Levinsky

    Non financial conflicts of interest in research

    N Engl J Med

    (2002)
  • Preserving Public TrustAccreditation and Human Research Participant Protection Programs

    (2001)
  • J.S. Alpert et al.

    Conflicts of interest

    Arch Intern Med

    (2002)
There are more references available in the full text version of this article.

Cited by (28)

  • Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals

    2012, Revista Portuguesa de Cardiologia
    Citation Excerpt :

    However, 90% of the editors considered the ICMJE COI proposal of potential value to their particular journals and most of them declared that they were willing to implement it within a relatively short period of time (Table 4). Research is becoming progressively complex and quality standards increasingly demanding.17–24 As a result, conducting clinical studies is becoming more expensive and the role of sponsors to ensure the viability of research projects is becoming critical.

View all citing articles on Scopus
View full text